Frances E. Leland

1.9k total citations
12 papers, 1.6k citations indexed

About

Frances E. Leland is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Frances E. Leland has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Frances E. Leland's work include Virus-based gene therapy research (5 papers), Animal Genetics and Reproduction (5 papers) and RNA Interference and Gene Delivery (4 papers). Frances E. Leland is often cited by papers focused on Virus-based gene therapy research (5 papers), Animal Genetics and Reproduction (5 papers) and RNA Interference and Gene Delivery (4 papers). Frances E. Leland collaborates with scholars based in United States, Canada and China. Frances E. Leland's co-authors include Savio L.C. Woo, Milton J. Finegold, Mark A. Kay, Gretchen Darlington, Katherine P. Ponder, Dwight A. Bellinger, Charles N. Landen, Arthur R. Thompson, Sanjeev Gupta and Jayanta Roy Chowdhury and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Chemical Physics.

In The Last Decade

Frances E. Leland

12 papers receiving 1.5k citations

Peers

Countries citing papers authored by Frances E. Leland

Since Specialization

Citations

This map shows the geographic impact of Frances E. Leland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances E. Leland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances E. Leland more than expected).

Fields of papers citing papers by Frances E. Leland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances E. Leland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances E. Leland. The network helps show where Frances E. Leland may publish in the future.

Co-authorship network of co-authors of Frances E. Leland

This figure shows the co-authorship network connecting the top 25 collaborators of Frances E. Leland. A scholar is included among the top collaborators of Frances E. Leland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances E. Leland. Frances E. Leland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. 1996 ·PubMed ·Stephen Gottschalk, James T. Sparrow, (unknown), Martha P. Mims, Frances E. Leland, Savio L.C. Woo, (unknown)	205
2	Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes 1995 ·Hepatology ·Mark A. Kay, Frank L. Graham, Frances E. Leland, Savio L.C. Woo	97
3	In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. 1994 ·Proceedings of the National Academy of Sciences ·Mark A. Kay, Charles N. Landen, (unknown), (unknown), Frances E. Leland, Sandra Wiehle, B Fang, Dwight A. Bellinger, Milton J. Finegold, Arthur R. Thompson	216
4	In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs 1993 ·Science ·Mark A. Kay, (unknown), Charles N. Landen, Dwight A. Bellinger, Frances E. Leland, (unknown), Milton J. Finegold, Arthur R. Thompson, Marjorie S. Read, Kenneth M. Brinkhous, Savio L.C. Woo	249
5	Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo 1992 ·Human Gene Therapy ·Mark A. Kay, Qiutang Li, Ta-Jen Liu, Frances E. Leland, (unknown), Milton J. Finegold, Savio L.C. Woo	155
6	Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. 1992 ·Proceedings of the National Academy of Sciences ·Mark A. Kay, (unknown), (unknown), Frances E. Leland, (unknown), Katherine P. Ponder, (unknown), Milton J. Finegold, Gretchen Darlington, William J. Pokorny	207
7	Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. 1991 ·Proceedings of the National Academy of Sciences ·Katherine P. Ponder, Sanjeev Gupta, Frances E. Leland, Gretchen Darlington, Milton J. Finegold, Janet L. DeMayo, Fred D. Ledley, Jayanta Roy Chowdhury, Savio L.C. Woo	297
8	Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma. 1989 ·PubMed ·(unknown), Frances E. Leland, Motowo Nakajima, Stephen J. LeGrue	19
9	Effect of Estrogen-Promoted Bacterial Infections of the Rat Uterus on Bioassay of Mammalian Cell Growth Factor Activities in Uterine Luminal Fluid 1983 ·Biology of Reproduction ·Frances E. Leland, Dennis F. Kohn, David A. Sirbasku	7
10	Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture 1982 ·In Vitro Cellular & Developmental Biology - Plant ·Tatsuhiko N. Ikeda, (unknown), David Danielpour, (unknown), Masayoshi Iio, Frances E. Leland, David A. Sirbasku	54
11	Properties of a growth factor activity present in crude extracts of rat uterus 1981 ·Journal of Cellular Physiology ·David A. Sirbasku, Frances E. Leland, (unknown)	21
12	Delta-Potential Function Model. II. Aromatic Hydrocarbons 1956 ·The Journal of Chemical Physics ·Arthur A. Frost, Frances E. Leland	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact